NCT06868732 2026-03-30
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
Clinical Trials
10 trialsNCT06823245 2025-02-12
Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06585059 2024-09-05
Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT03681483 2024-07-10
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT06329895 2024-07-05
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT06378658 2024-07-05
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT06360211 2024-07-03
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT06221475 2024-06-28
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
Bayer
Phase 1 Completed
NCT05489731 2023-06-15
VIC-1911
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Phase 1 Unknown
NCT04990063 2021-08-04
Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)
Tang-Du Hospital
Phase 1 Unknown